[Optimization of the method of treatment of chronic viral hepatitis C with pegylated interferon-alfa and ribavirin]. [electronic resource]
- Przeglad epidemiologiczny 2006
- 237-46 p. digital
Publication Type: Journal Article; Review
0033-2100
Antiviral Agents--therapeutic use Dose-Response Relationship, Drug Drug Carriers--therapeutic use Drug Resistance, Viral Drug Therapy, Combination Hepacivirus--drug effects Hepatitis C, Chronic--drug therapy Humans Interferon alpha-2 Interferon-alpha--therapeutic use Polyethylene Glycols Recombinant Proteins Retreatment--methods Ribavirin--therapeutic use Secondary Prevention Treatment Outcome